This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI BOVINE CD5
catalog :
MCA6082
quantity :
0.1 mg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
B29A
reactivity :
bovine
application :
flow cytometry
product information
Entity Category :
Antibodies
Product Code :
MCA6082
Description :
MOUSE ANTI BOVINE CD5
Specificity :
CD5
Target Species :
Bovine
Host :
Mouse
Format :
Con S/N
Isotypes :
IgG2a
Applications :
F
Application Types :
Flow Cytometry
Clone :
B29A
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0016021, GO:0005044
GO Terms :
macrophage receptor activity, transmembrane
Uniprot Accessions :
P19238
Gene :
CD5
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=280745
EntityFormats :
Con S/N
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Concentrated tissue culture supernatant - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.